1. Home
  2. PRLD vs DFP Comparison

PRLD vs DFP Comparison

Compare PRLD & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

N/A

Current Price

$3.79

Market Cap

529.1M

Sector

Health Care

ML Signal

N/A

Logo Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

DFP

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

N/A

Current Price

$18.95

Market Cap

424.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PRLD
DFP
Founded
2016
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
529.1M
424.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PRLD
DFP
Price
$3.79
$18.95
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $9.20
N/A
AVG Volume (30 Days)
★ 395.6K
89.0K
Earning Date
11-11-2026
01-01-0001
Dividend Yield
N/A
★ 6.73%
EPS Growth
★ 23.21
N/A
EPS
N/A
★ N/A
Revenue
★ $12,140,000.00
N/A
Revenue This Year
$258.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 73.43
N/A
52 Week Low
$1.15
$18.67
52 Week High
$6.83
$22.11

Technical Indicators

Market Signals
Indicator
PRLD
DFP
Relative Strength Index (RSI) 32.49 27.62
Support Level $3.40 N/A
Resistance Level $4.10 $21.09
Average True Range (ATR) 0.28 0.22
MACD -0.08 -0.04
Stochastic Oscillator 11.76 21.41

Price Performance

Historical Comparison
PRLD
DFP

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.

Share on Social Networks: